| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/16/1997 | EP0783505A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE |
| 07/16/1997 | EP0783503A1 2,7-SUBSTITUTED OCTAHYDRO-1H-PYRIDO 1,2-a]PYRAZINE DERIVATIVES |
| 07/16/1997 | EP0783499A1 Benzofuran derivatives as tachykinin antagonists |
| 07/16/1997 | EP0783498A1 Substituted aryl piperazines as neurokinin antagonists |
| 07/16/1997 | EP0783494A1 Certain aminomethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands |
| 07/16/1997 | EP0783490A1 1-acyl-4-aliphatylaminopiperidine compounds |
| 07/16/1997 | EP0783488A1 Five membered heterocyclic compounds |
| 07/16/1997 | EP0783486A1 Novel prostaglandin synthase inhibitors |
| 07/16/1997 | EP0783320A1 Protection of hemopoietic cells during chemotherapy or radiotherapy |
| 07/16/1997 | EP0783318A1 Inhibitors of farnesyl-protein transferase |
| 07/16/1997 | EP0783305A1 Inhibitors of farnesyl-protein transferase |
| 07/16/1997 | EP0783303A1 Use of aromatic halides for treating mammalian cell proliferation |
| 07/16/1997 | EP0726903B1 Matrix metalloprotease inhibitors |
| 07/16/1997 | EP0672056B1 Calcium channel blocking polypeptides from filistata hibernalis |
| 07/16/1997 | EP0601154B1 Bpc peptides, their preparation and use |
| 07/16/1997 | EP0586618B1 The use of nucleic acid analogues in diagnostics and analytical procedures |
| 07/16/1997 | CN1154699A (Azetidin-1-ylalkyl) lactams as tachykinin antagonists |
| 07/16/1997 | CN1154365A Substituted quinoline-2-carboxylic acid amides, their preparation and their use as medicaments and intermediate products |
| 07/16/1997 | CN1154245A Turtle oil, soft-shelled turtle oil and compositions contg. same, and the use thereof |
| 07/15/1997 | US5648492 Process for preparing isoquinoline compounds |
| 07/15/1997 | US5648486 Compounds and methods for the treatment of inflammatory and immune disorders |
| 07/15/1997 | US5648467 Human cytokine |
| 07/15/1997 | US5648385 Retinoid-like compounds |
| 07/15/1997 | US5648380 Anti-inflammatory wound healing compositions and methods for preparing and using same |
| 07/15/1997 | US5648374 Benzospiroalkene compounds |
| 07/15/1997 | US5648373 CoA-IT and PAF inhibitors |
| 07/15/1997 | US5648368 Fibrinogen receptor antagonists |
| 07/15/1997 | US5648365 Diarylalkyl piperidines useful as multi-drug resistant tumor agents |
| 07/15/1997 | US5648346 Antimicrobial carbacephem-quinolones |
| 07/15/1997 | US5648335 Prevention and treatment of peripheral neuropathy |
| 07/15/1997 | US5648239 Human camp-dependent protein kinase inhibitor homolog |
| 07/15/1997 | US5648238 Human protein kinase C inhibitor homolog |
| 07/15/1997 | US5648072 Methods of inducing gamma interferon and stimulating blood cell populations using natural killer stimulatory factor |
| 07/15/1997 | CA2063400C Inhibition of the n-end rule pathway in living cells |
| 07/10/1997 | WO1997024445A1 Recombinant fusion proteins to growth hormone and serum albumin |
| 07/10/1997 | WO1997024441A1 Nucleic acids encoding interferon gamma inducing factor-2 |
| 07/10/1997 | WO1997024369A1 Growth-hormone secretagogues |
| 07/10/1997 | WO1997024356A1 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives |
| 07/10/1997 | WO1997024355A1 Pyrido (2,3-b) pyrazine derivatives |
| 07/10/1997 | WO1997024350A1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
| 07/10/1997 | WO1997024349A1 1-benzenesulfonyl pyrrolidine derivatives as bradykinin receptor antagonists |
| 07/10/1997 | WO1997024348A1 ((3'-thioxacyclohex-1'-enyl))-but-3'-ene-1'-ynyl)aryl and heteroaryl carboxylic acids and esters having retinoid-like biological activity |
| 07/10/1997 | WO1997024342A1 Thiol derivatives with metallopeptidase inhibitory activity |
| 07/10/1997 | WO1997024334A1 Benzimidazole derivatives |
| 07/10/1997 | WO1997024324A1 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists |
| 07/10/1997 | WO1997024138A2 Medical use of proteases |
| 07/10/1997 | WO1997024135A1 Amidino protease inhibitors |
| 07/10/1997 | WO1997024134A1 A pharmaceutical composition comprising plant worms and muirapuama |
| 07/10/1997 | WO1997024124A1 Vitronectin receptor antagonists |
| 07/10/1997 | WO1997024123A1 Use of polyamine site antagonist for the manufacture of a medicament for the treatment of ischemic disorders of the eye |
| 07/10/1997 | WO1997024122A1 Vitronectin receptor antagonists |
| 07/10/1997 | WO1997024119A1 Vitronectin receptor antagonists |
| 07/10/1997 | WO1997015555A3 Imidazole derivatives and the use thereof as nitrogen monoxide synthase inhibitors |
| 07/10/1997 | DE19600480A1 Verwendung von Serin-Proteinasen gegen Akne und entzündete Comedonen Use of serine proteinases against acne and inflamed comedones |
| 07/10/1997 | CA2241913A1 Use of polyamine site antagonist for the manufacture of a medicament for the treatment of ischemic disorders of the eye |
| 07/10/1997 | CA2241724A1 Vitronectin receptor antagonists |
| 07/10/1997 | CA2241690A1 Pyrido(2,3-b)pyrazine derivatives |
| 07/10/1997 | CA2241633A1 Vitronectin receptor antagonists |
| 07/10/1997 | CA2241414A1 Thiol derivatives with metallopeptidase inhibitory activity |
| 07/10/1997 | CA2240401A1 ((3"-thioxacyclohex-1"-enyl))-but-3'-ene-1'-ynyl)aryl and heteroaryl carboxylic acids and esters having retinoid-like biological activity |
| 07/10/1997 | CA2240292A1 Recombinant fusion proteins to growth hormone and serum albumin |
| 07/10/1997 | CA2240257A1 A pharmaceutical composition comprising plant worms and muirapuama |
| 07/10/1997 | CA2238885A1 Nucleic acids encoding interferon gamma inducing factor-2 |
| 07/09/1997 | EP0783037A1 Polypeptides with a dopaminergic receptor (D2-R and D3-R) activity and use of these polypeptides to screen substances having a selective activity on these polypeptides |
| 07/09/1997 | EP0783002A2 Dual action inhibitors |
| 07/09/1997 | EP0783001A1 Androstenones |
| 07/09/1997 | EP0782986A1 Novel heterocyclic derivatives, process for producing the same, and medicinal use thereof |
| 07/09/1997 | EP0782617A1 gp130 LACKING THE TRANSMEMBRANE DOMAIN |
| 07/09/1997 | EP0782582A1 EPIMERS OF (22RS)-N-(1,1,1-TRIFLUORO-2-PHENYLPROP-2-YL)-3-OXO-4-AZA-5$g(a)-ANDROST-1-ENE-17$g(b)-CARBOXAMIDE |
| 07/09/1997 | EP0782581A1 Cloning of an insulin-dependent membrane aminopeptidase from glut-4 vesicles |
| 07/09/1997 | EP0782574A1 Bicyclic carboxamides as 5-ht 1a? antagonists |
| 07/09/1997 | EP0782570A1 Substituted heteroaromatic compounds and their use in medicine |
| 07/09/1997 | EP0782568A1 Aromatic ethers derived from indols such as 5ht1-like ligands |
| 07/09/1997 | EP0782444A1 Method of inhibiting conditions associated with bradykinin |
| 07/09/1997 | EP0681580B1 Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides |
| 07/09/1997 | EP0677046B1 Piperazine derivatives as 5-ht antagonists |
| 07/09/1997 | EP0464084B1 Use of eicosapentaenoic acid for the treatment of cachexia |
| 07/09/1997 | CN1154110A Compounds useful as antiproliferative agents and GARFT inhibitors |
| 07/09/1997 | CN1153784A Biotin derivatives |
| 07/08/1997 | US5646313 Preparing enkephalinase inhibitors |
| 07/08/1997 | US5646308 Benzopyran derivatives |
| 07/08/1997 | US5646289 Reacting a 3-chloro-1,2,5-thiadiazole with alkali metal bis(trialkyl or arylsilyl)amide; dechlorination; treating nervous system disorders |
| 07/08/1997 | US5646272 Bile acid conjugates of proline hydroxylase inhibitors |
| 07/08/1997 | US5646190 Acne treating-wound healing compositions and methods for preparing and using same |
| 07/08/1997 | US5646172 Method of inducing antiandrogenic activity using imidazolidines substituted with a heterocycle |
| 07/08/1997 | US5646170 Tetrazole alkyl amide acat inhibitors |
| 07/08/1997 | US5646158 For treating allergic and inflammatory diseases and for inhibiting the production of tumor necrosis factor |
| 07/08/1997 | US5646152 Treating psychological disorders with corticotropin releasing factor antagonists |
| 07/08/1997 | US5646149 Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
| 07/08/1997 | US5646144 For treating disorders in which substance p plays a part in development |
| 07/08/1997 | US5646143 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides |
| 07/08/1997 | US5646141 Compounds useful as antiproliferative agents and GARFT inhibitors |
| 07/08/1997 | US5646140 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity |
| 07/08/1997 | US5646139 Antimicrobial carbapenem quinolones |
| 07/08/1997 | US5646137 Administering antiestrogen, i.e. raloxifene, and a progestin |
| 07/08/1997 | US5646134 Inhibiting bone resorption |
| 07/08/1997 | US5646132 2(1H)-quinolone compounds |
| 07/08/1997 | US5646129 Exposing mesenchymal cells to hyaluronic acid |
| 07/08/1997 | US5646116 Administering insulin-like growth factor i to a mammal |
| 07/08/1997 | US5646113 Treatment of partial growth hormone insensitivity syndrome |